“Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP)”, ADMET DMPK, vol. 4, no. 4, pp. 302–313, Dec. 2016, doi: 10.5599/admet.4.4.322.